Glioblastoma is the diagnosis that neuro-oncologists dread and patients fear, a fast-growing brain cancer that resists ...

Chordoma is a rare tumor characterized by poor prognosis, limited therapeutic options, and a high rate of recurrence. Despite ...

An interdisciplinary multi-center research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the ...

Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells. What makes it ...

MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.

Pancreatic cancer may evade the immune system not by accident but by actively switching off internal danger signals through ...

A compound from ginger stops cancer cells from making fats and drains their energy, exposing a metabolic weakness in cancer cells.

New research shows a common skin fungus can help melanoma spread by changing cancer cell movement and energy use.

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...

GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026 Phase 1 protocol allows multiple solid tumor types known to express B7-H3 Unaudited proforma cash balance as of January 31, ...